13-281 Donadeo Innovation Centre for Engineering
9211 - 116 Street
Edmonton, AB, Canada T6G 1H9
Artificial organelle; Living-nonliving hybrid systems; Drug delivery systems; Oral vaccine delivery; Transdermal vaccine delivery using microneedles; Pandemic disease control measures
Dr. Hyo-Jick Choi is a firm believer of the decisive role of innovative technologies in improving the quality of life. With this belief, he has dedicated his research career to engineer sustainable technologies, which are focused on resolving global issues in environment and health. His past research areas include development of new nanobiological systems and their applications in fabrication of engineering devices with life-like functionality, artificial cells, water purification membrane, carbon sequestration/biofuel production, and transdermal influenza vaccine delivery using microneedles. His current and future research interests are:
- advanced living/nonliving hybrid systems for energy production and environmental control measures, and
- nanotechnology to combat epidemic/pandemic disease
- development of new vaccination technology (transdermal/oral vaccine delivery design)
- development of airborne pathogen deactivation methods.
The overall goal of his research is to develop nano-scale systems with precisely tailored materials by using interdisciplinary approach and focus on their commercial applications in energy, environment, and global health problems.
Dr. Hyo-Jick Choi is an assistant professor in the Department of Chemical & Materials Engineering at the University of Alberta, and runs a sustainable engineering and drug delivery design (SEƎD) lab investigating new materials directed towards health and environmental applications. He has amassed knowledge in different disciplines of science as the result of his diverse background. He received his B.S. and M.S. degrees in Ceramic Engineering from Yonsei University in Korea in 1999 and 2001, respectively. He continued his Ph.D. studies in Biomedical Engineering at UCLA (2002-2006) and at the University of Cincinnati (2006-2007). His research resulted in generation of two start-up companies. After completing his Ph.D. studies, he worked in the capacity of R&D manager in the company and played critical role in the commercialization of these technologies. He then conducted postdoctoral research in the School of Chemical and Biomolecular Engineering at Georgia Institute of Technology (2009-2010). Prior to joining the University of Alberta, Dr. Choi served as research assistant professor in Environmental Engineering Department at the University of Cincinnati, where he worked as the Principal Investigator of oral vaccine delivery project.